Saw Palmetto Extract

Saw palmetto extract is a botanical ingredient derived from the berries of Serenoa repens, a small palm tree native to the southeastern United States. The extract is standardised to a minimum of 85–95% fatty acids and sterols, which are the primary active constituents. It is one of the most familiar and commercially understood botanical actives across EU and US gummy markets, particularly in male wellness and healthy ageing ranges.

Brands use saw palmetto extract in gummies to target prostate health, urinary comfort, and hair and scalp support. It is a mid-cost ingredient with good gummy applicability, heat stability, and solubility. Because it is a botanical on the EU on-hold list, no authorised health claims are permitted under Reg. (EU) 432/2012, and claim strategy must be reviewed per project.

Origin and history

Saw palmetto has a long history of traditional use by Native American tribes in the southeastern United States, who used the berries as a food and for general wellness. European settlers adopted the plant in the 19th century, and by the early 20th century saw palmetto extract was a common ingredient in herbal medicine across Europe and North America.

Industrial production of saw palmetto extract involves harvesting the ripe berries, drying them, and extracting the fatty acids and sterols using a solvent (typically ethanol or CO₂). The extract is then standardised to a consistent potency. Most commercial supply comes from wild-harvested or cultivated sources in Florida, Georgia, and the Carolinas.

Scientific overview

The primary active constituents in saw palmetto extract are fatty acids (lauric, oleic, myristic, palmitic) and phytosterols (beta-sitosterol, stigmasterol). These compounds are thought to inhibit the enzyme 5-alpha-reductase, which converts testosterone to dihydrotestosterone (DHT). DHT is associated with prostate enlargement and hair follicle miniaturisation. The extract also has mild anti-androgenic and anti-oestrogenic effects.

Bioavailability of saw palmetto extract is moderate. The fatty acids are lipid-soluble and are better absorbed when taken with a meal. Standardised extracts (85–95% fatty acids) are preferred for consistent dosing. The extract is heat-stable and soluble in gummy formulations, making it suitable for gummy manufacturing.

Manufacturing watchpoints include the bitter taste of the extract, which may require masking or flavour optimisation. The cost-per-mg is mid-tier, and the extract is stable under standard gummy processing conditions. Overdosing is not a concern, but the minimum effective dose in clinical literature is 160 mg per day.

Saw palmetto extract is one of the most familiar and commercially understood botanical actives in gummy manufacturing. It is positioned primarily for prostate health, urinary comfort, and hair and scalp support, making it a staple in male wellness and healthy ageing ranges. It pairs well with Zinc, Lycopene, and Copper for synergistic formulations.

From a formulation and manufacturing perspective, saw palmetto extract is heat-stable, soluble in gummy bases, and has a mid-cost tier. The slightly bitter berry taste can be managed with flavour masking. Gummy-optimised dosing typically ranges from 160 mg to 640 mg per daily serving. DAT confirms final dosage and formulation per project after formula review.

For pack copy, brands must avoid disease claims (including BPH, prostate cancer, hair loss treatment) and cannot use authorised health claims under Reg. (EU) 432/2012. Non-health positioning (e.g., "traditional herbal support") or co-formulation with claim-authorised nutrients (e.g., Zinc for prostate health) is recommended. DAT reviews claim strategy per project. No certification promises or shelf-life claims should appear on pack until confirmed per project with supplier documentation and stability data.